Skip to content
Conversations in Lung Cancer Research cover art

All episodes

Conversations in Lung Cancer Research, 78 episodes.

#
Title
1

The Evolving Role of Radiation Oncology in Lung Cancer Management

2

Bispecific Antibodies in Thoracic Oncology

3

Targeting VEGF in Thoracic Oncology

4

The Evolving Landscape of ROS1-positive NSCLC

5

Prof Zarnie Lwin OAM: Mentorship, Research, and the Future of Lung Cancer Treatment

6

Smoking Stigma and Lung Cancer Care in the Screening Era

7

Dr. Jazmin Eckhaus: Robotic Innovations and Ethics in Thoracic Surgery

8

Immunotherapy in Thoracic Cancers: Applying Broad IO Access Across Thoracic Malignancies

9

Immunotherapy in Thoracic Cancers: From Indication-Based to Biology-Driven

10

The Evolving Landscape of BRAF-Mutated NSCLC in Australia

11

Thymic Cancer: The Lesser-Known Thoracic Tumours

12

A/Prof Surein Arulananda: A Masterclass in Career Growth

13

TOGA ASM 2026: Program Review

14

ALK TKI Sequencing in the Australian Landscape

15

Professor Michael Millward: Clinical Insights in Lung Cancer Research

16

Dr. Megan Sanders: From Science to TOGA Leadership

17

Lung Cancer Research: 2025 Year in Review

18

New and Emerging Practice Standards in ES-SCLC

19

Exploring Lung Cancer Care and Research in New Zealand

20

Challenging Ageism: Optimising Lung Cancer Treatment in Older Adults

21

Prof. Anna Nowak: A Journey from Oncology Lab to Leadership

22

CNS Progression in Lung Cancer: A Practical Conversation on Best Practices

23

A/Prof Fiona Hegi Johnson: Navigating Careers and Innovations in Lung Cancer Research

24

Prof Shankar Siva: Pushing Boundaries in Radiation Oncology

25

The Emerging Role of the Microbiome in Lung Cancer and Immunotherapy Response

26

Lessons from Fellowships and building Clinical Trials Units

27

Prof Wendy Cooper: Journey of a Thoracic Pathologist

28

Vaccines in Thoracic Oncology: The Next Frontier in Immunotherapy

29

The Role of Liquid Biopsy in Modern Oncology

30

Exploring EGFR Exon 20 Insertion Mutations

31

From Clinical Research to Leadership: A Conversation with Prof. Michael Boyer

32

Introducing Conversations in Lung Cancer Research - Trailer

33

Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy

34

Hit It With Your Best Shot- The Case for IO in Early-Stage NSCLC in a Once in a Lifetime World

35

Large-Cell Neuroendocrine Carcinoma of the Lung (LCNEC): Challenges in Diagnosis and Treatment

36

Management of Limited-Stage Small Cell Lung Cancer (LS-SCLC)

37

NTRK1, 2,3 And Other Rare Mutations In NSCLC

38

Decoding Perioperative Immunotherapy In NSCLC

39

Access to New Medicines: Which Surrogate Endpoints Matter

40

Lung Cancer Nurses: Essential, Beneficial and a Key Link In Lung Cancer Screening

41

Underutilisation of Radiotherapy in Lung Cancer Treatment

42

Revolutionising Lung Cancer Healthcare with AI: Unlocking the Future

43

Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer

44

Lung cancer Screening and Moving from Concept to Roll Out

45

Early Recovery After Surgery - Guidelines and Multidisciplinary Considerations

46

Nature and nurture: lung cancer risk and implications for future screening

47

Operability in Stage III NSCLC

48

NSCLC and KRAS Mutations

49

Treatment Considerations in ALK-Positive NSCLC

50

Celebrating Female Leadership in Medical Research

51

Brain metastases in NSCLC

52

NGS panels in lung cancer

53

Lung Cancer Screening and its impact on patient care in Australia

54

The Management of Stage III NSCLC

55

The Changing Course of Outcomes in Early Stage NSCLC: Surgical and Respiratory Medicine Considerations

56

Cardiotoxicity and Radiation Therapy - Considerations for Lung Cancer

57

Accelerating Progress in Oncogene-driven Lung Cancer

58

Access to Molecular Diagnostics and Treatments Across ANZ: The Past, Present, Future

59

Practical smoking cessation advice for health care providers

60

Consider Every Trial as a TeleTrial

61

EGFR Update: Improving Outcomes in EGFR-Mutated Non-Small-Cell Cancer

62

The need for a National Clinical Quality Registry in Lung Cancer

63

ALK treatment considerations in NSCLC

64

Stigma and Nihilism In Lung Cancer : A Call to Action

65

Challenging the Lung Cancer Stigma

66

The Value of Comprehensive Genomic Profiling in Lung Cancer

67

Inflammation And Its Impact On The Development & Treatment Of Lung Cancer

68

Optimising Diagnosis & Treatment Pathways For Lung Cancer Patients

69

Long Term Survivorship: Thriving with Metastatic Lung Cancer

70

Women and Lung Cancer: The Rising Tide

71

Practical Perspectives: Shifting the Needle in Small Cell Lung Canceer

72

Lung cancer screening works!

73

Dreaming of Better Treatments for Mesothelioma

74

Lung Cancer Careers: Preceptorship Reflections

75

Cancer won't wait: A Cancer Australia Perspective

76

2020 Wrap: Remarkable Progress In Diagnosing & Treating Lung Cancer

77

Redefining Survival In Lung Cancer: Meet Alexandra

78

Improving Survival In Oncogene Driven Lung Cancer